AI imaging measures change during cardiac amyloidosis treatment
Source check: Source checked. Not independent scientific confirmation.
Finding: Automated cardiac segmentation quantified serial SPECT/CT scans in 45 patients receiving transthyretin amyloidosis therapies. Several tracer-uptake markers decreased after treatment, and selected changes were associated with functional measures. These exploratory observational results do not prove treatment causality or removal of amyloid deposits; affected-volume measures did not significantly decline.
Technology: TotalSegmentator; foundational deep-learning CT segmentation
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A pretrained anatomical segmentation network maps cardiac structures to SPECT, enabling standardized regional tracer measurements over time.
- Test and result
- Serial baseline/follow-up clinical imaging, automated cardiac-region quantification and exploratory associations with functional measurements.
- Limitation / still unknown
- Controlled treatment effects, cross-scanner generalizability and clinical decision benefit remain unestablished; the paper has inconsistent aggregate marker counts and small treatment subgroups.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://link.springer.com/article/10.1007/s00259-025-07673-6
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary relevant model Methods, Results and limitations; exact primary identity and current primary PubMed correction/retraction relationships checked..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.